Litsa Karageorgos

1.6k total citations
35 papers, 1.2k citations indexed

About

Litsa Karageorgos is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Litsa Karageorgos has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Litsa Karageorgos's work include Lysosomal Storage Disorders Research (16 papers), Trypanosoma species research and implications (8 papers) and Cellular transport and secretion (6 papers). Litsa Karageorgos is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Trypanosoma species research and implications (8 papers) and Cellular transport and secretion (6 papers). Litsa Karageorgos collaborates with scholars based in Australia, United States and Ireland. Litsa Karageorgos's co-authors include Uwe H. Stroeher, Paul A. Manning, Renato Morona, John J. Hopwood, Doug A. Brooks, C. J. Burrell, Peng Li, Peter J. Meikle, Melissa H. Brown and Elizabeth Isaac and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical Journal and Clinical Chemistry.

In The Last Decade

Litsa Karageorgos

35 papers receiving 1.1k citations

Peers

Litsa Karageorgos

PHYSI

EPIDE

ENDOC

IMMUN

Sven Müller‐Loennies Germany

Wenwei Li China

J. P. Kraehenbuhl Switzerland

Kassidy K. Huynh Canada

J C Mazié France

Atsuki Nara Japan

Walter Berón Argentina

Ludovic Huot France

Tetsuya Yoshida Japan

Lara J. Kohler United States

Sven Müller‐Loennies Germany

Litsa Karageorgos

144 ×0.3

PHYSI

187 ×0.6

EPIDE

634 ×2.2

191 ×0.7

ENDOC

391 ×2.1

IMMUN

Citations per year, relative to Litsa Karageorgos Litsa Karageorgos (= 1×) peers Sven Müller‐Loennies

Countries citing papers authored by Litsa Karageorgos

Since Specialization

Citations

This map shows the geographic impact of Litsa Karageorgos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Litsa Karageorgos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Litsa Karageorgos more than expected).

Fields of papers citing papers by Litsa Karageorgos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Litsa Karageorgos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Litsa Karageorgos. The network helps show where Litsa Karageorgos may publish in the future.

Co-authorship network of co-authors of Litsa Karageorgos

This figure shows the co-authorship network connecting the top 25 collaborators of Litsa Karageorgos. A scholar is included among the top collaborators of Litsa Karageorgos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Litsa Karageorgos. Litsa Karageorgos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brooks, Robert D., Mark A. Miles, Zivile Useckaite, et al.. (2024). Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system. Cancer Letters. 585. 216639–216639. 8 indexed citations

Logan, Jessica M., Alexandra Sorvina, I. R. Johnson, et al.. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific Data. 11(1). 852–852. 2 indexed citations

Prabhakaran, Sarita, Ashley M. Hopkins, Benjamin S.‐Y. Ung, et al.. (2023). Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers. 15(18). 4631–4631. 3 indexed citations

Winner, Leanne K., Helen Beard, Litsa Karageorgos, et al.. (2023). The ovine Type II Gaucher disease model recapitulates aspects of human brain disease.. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166658–166658. 2 indexed citations

Logan, Jessica M., Alexandra Sorvina, Sarita Prabhakaran, et al.. (2023). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(4). 723–728. 1 indexed citations

Prabhakaran, Sarita, Alexandra Sorvina, Benjamin S.‐Y. Ung, et al.. (2022). Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers. Molecular Diagnosis & Therapy. 27(1). 49–60. 11 indexed citations

Hickey, Shane M., Benjamin S.‐Y. Ung, Christie A. Bader, et al.. (2021). Fluorescence Microscopy—An Outline of Hardware, Biological Handling, and Fluorophore Considerations. Cells. 11(1). 35–35. 63 indexed citations

Tomanin, Rosella, Litsa Karageorgos, Alessandra Zanetti, et al.. (2018). Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in theARSBgene. Human Mutation. 39(12). 1788–1802. 50 indexed citations

Karageorgos, Litsa, Leanne K. Hein, Tina Rozaklis, et al.. (2016). Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease. Neurobiology of Disease. 91. 143–154. 15 indexed citations

10.

Karageorgos, Litsa, et al.. (2010). Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genes. Cytotherapy. 12(3). 400–407. 2 indexed citations

11.

Karageorgos, Litsa, Doug A. Brooks, A.C. Pollard, et al.. (2007). Mutational analysis of 105 mucopolysaccharidosis type VI patients. Human Mutation. 28(9). 897–903. 97 indexed citations

12.

Karageorgos, Litsa, Doug A. Brooks, Paul Harmatz, et al.. (2006). Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. Molecular Genetics and Metabolism. 90(2). 164–170. 29 indexed citations

13.

Karageorgos, Litsa, Paul Harmatz, A.C. Pollard, et al.. (2004). Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy. Human Mutation. 23(3). 229–233. 33 indexed citations

14.

Karageorgos, Litsa, et al.. (1997). Lysosomal Biogenesis in Lysosomal Storage Disorders. Experimental Cell Research. 234(1). 85–97. 66 indexed citations

15.

Karageorgos, Litsa. (1996). Structure and Sequence of the Human Sulphamidase Gene. DNA Research. 3(4). 269–271. 36 indexed citations

16.

Stroeher, Uwe H., Litsa Karageorgos, Renato Morona, & Paul A. Manning. (1995). In vibrio cholerae serogroup O 1, rfaD is closely linked to the rfb operon. Gene. 155(1). 67–72. 13 indexed citations

17.

Stroeher, Uwe H., Litsa Karageorgos, Melissa H. Brown, Renato Morona, & Paul A. Manning. (1995). A putative pathway for perosamine biosynthesis is the first function encoded within the rfb region of Vibrio cholerae O1. Gene. 166(1). 33–42. 42 indexed citations

18.

Manning, Paul A., Uwe H. Stroeher, Litsa Karageorgos, & Renato Morona. (1995). Putative O-antigen transport genes within the rfb region of Vibrio cholerae O1 are homologous to those for capsule transport. Gene. 158(1). 1–7. 31 indexed citations

19.

Li, P., et al.. (1994). Initiation of reverse transcription during cell-to-cell transmission of human immunodeficiency virus infection uses pre-existing reverse transcriptase. Journal of General Virology. 75(8). 1917–1926. 7 indexed citations

20.

Karageorgos, Litsa, Peng Li, & C. J. Burrell. (1993). Characterization of HIV Replication Complexes Early after Cell-to-Cell Infection. AIDS Research and Human Retroviruses. 9(9). 817–823. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact